ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,675.68
1.18%
Gold vs US Dollar
2,302.00
-0.02%
Brent Oil
83.235
0.57%
Bitcoin
63,876.22
-0.03%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Bioinvent International Ab (0H22)

  7. Bioinvent International Ab (0H22) News

Bioinvent International Ab (0H22)

Bioinvent International Ab
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0H22
DateTimeSourceHeadlineSymbolCompany
29/04/202110:52PR Newswire (US)Resolutions at BioInvent's Annual General Meeting 2021LSE:0H22Bioinvent International Ab
29/04/202110:49PR Newswire (US)Resolutions at BioInvent's Annual General Meeting 2021LSE:0H22Bioinvent International Ab
12/04/202106:44PR Newswire (US)BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric cancerLSE:0H22Bioinvent International Ab
12/04/202106:41PR Newswire (US)BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric cancerLSE:0H22Bioinvent International Ab
08/04/202107:53PR Newswire (US)BioInvent International's Annual Report 2020 publishedLSE:0H22Bioinvent International Ab
08/04/202107:50PR Newswire (US)BioInvent International's Annual Report 2020 publishedLSE:0H22Bioinvent International Ab
31/03/202107:50PR Newswire (US)Change in the number of shares and votes in BioInvent International ABLSE:0H22Bioinvent International Ab
31/03/202107:48PR Newswire (US)Change in the number of shares and votes in BioInvent International ABLSE:0H22Bioinvent International Ab
23/02/202108:22PR Newswire (US)BioInvent International Financial Statement January 1 - December 31, 2020LSE:0H22Bioinvent International Ab
23/02/202108:21PR Newswire (US)BioInvent International Financial Statement January 1 - December 31, 2020LSE:0H22Bioinvent International Ab
09/12/202008:15PR Newswire (US)Nomination Committee appointed for BioInvent International's Annual General Meeting 2021LSE:0H22Bioinvent International Ab
09/12/202008:09PR Newswire (US)Nomination Committee appointed for BioInvent International's Annual General Meeting 2021LSE:0H22Bioinvent International Ab
07/12/202007:44PR Newswire (US)Record date for reverse share split in BioInvent International determinedLSE:0H22Bioinvent International Ab
07/12/202007:42PR Newswire (US)Record date for reverse share split in BioInvent International determinedLSE:0H22Bioinvent International Ab
27/11/202010:44PR Newswire (US)Resolutions at the Extraordinary General Meeting in BioInvent on November 27, 2020LSE:0H22Bioinvent International Ab
27/11/202010:42PR Newswire (US)Resolutions at the Extraordinary General Meeting in BioInvent on November 27, 2020LSE:0H22Bioinvent International Ab
29/10/202007:17PR Newswire (US)BioInvent Interim Report January 1 - September 30, 2020LSE:0H22Bioinvent International Ab
29/10/202007:15PR Newswire (US)BioInvent Interim Report January 1 - September 30, 2020LSE:0H22Bioinvent International Ab
27/08/202007:18PR Newswire (US)BioInvent Interim Report January 1 - June 30, 2020LSE:0H22Bioinvent International Ab
27/08/202007:16PR Newswire (US)BioInvent Interim Report January 1 - June 30, 2020LSE:0H22Bioinvent International Ab
18/06/202014:21PR Newswire (US)Proposal for a New Board Member to be Elected at the Extraordinary General Meeting on July 3, 2020LSE:0H22Bioinvent International Ab
18/06/202014:18PR Newswire (US)Proposal for a New Board Member to be Elected at the Extraordinary General Meeting on July 3, 2020LSE:0H22Bioinvent International Ab
28/04/202007:17PR Newswire (US)BioInvent Interim Report January 1 - March 31, 2020LSE:0H22Bioinvent International Ab
28/04/202007:15PR Newswire (US)BioInvent Interim Report January 1 - March 31, 2020LSE:0H22Bioinvent International Ab
27/02/202006:54PR Newswire (US)BioInvent Financial Statement January 1 - December 31, 2019LSE:0H22Bioinvent International Ab
27/02/202006:52PR Newswire (US)BioInvent Financial Statement January 1 - December 31, 2019LSE:0H22Bioinvent International Ab
22/08/201907:47PR Newswire (US)BioInvent: Interim Report January 1 - June 30, 2019LSE:0H22Bioinvent International Ab
22/08/201907:44PR Newswire (US)BioInvent: Interim Report January 1 - June 30, 2019LSE:0H22Bioinvent International Ab
20/08/201909:54PR Newswire (US)BioInvent's Partner Oxurion NV has Reported Topline Month 3 Results of Phase lla Study Evaluating THR-317 (anti-PLGF), in Com...LSE:0H22Bioinvent International Ab
20/08/201909:52PR Newswire (US)BioInvent's Partner Oxurion NV has Reported Topline Month 3 Results of Phase lla Study Evaluating THR-317 (anti-PLGF), in Com...LSE:0H22Bioinvent International Ab
 Showing the most relevant articles for your search:LSE:0H22

Your Recent History

LSE
CHLL
Chill Brands
LSE
AGL
Angle
LSE
SRSP
Sirius Petroleum
LSE
SCE
Surface Transforms
LSE
INSG
Insig Ai
LSE
AAZ
Anglo Asian Mining
LSE
POS
Plexus
LSE
SCLP
Scancell
LSE
AAU
Ariana Resources
LSE
SBTX
Skinbiotherapeutics
LSE
BIRD
Blackbird
LSE
HUM
Hummingbird Resources
LSE
GFM
Griffin Mining
LSE
LLOY
Lloyds Banking
LSE
APTA
Aptamer
LSE
ALBA
Alba Mineral Resources
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved